- £10.40m
- £21.79m
- £59.17m
- 32
- 88
- 18
- 40
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 42.9 | 40.9 | 21.6 | 37.9 | 59.2 |
Cost of Revenue | |||||
Gross Profit | 14.2 | 11.3 | -1.95 | 14 | 28.9 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 64.2 | 96.6 | 63.7 | 46.9 | 72.5 |
Operating Profit | -21.2 | -55.7 | -42.1 | -8.99 | -13.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -25.1 | -59.1 | -44.1 | -12.3 | -18.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | -21.4 | -49.8 | -42.1 | -6.04 | -11.8 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -21.3 | -50.2 | -53.1 | -6.24 | -11.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -21.3 | -50.2 | -53.1 | -6.24 | -11.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.176 | -0.38 | -0.118 | -0.048 | -0.09 |